These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2192015)

  • 21. Abolition of the NMDA-mediated responses by a specific glycine antagonist, 6,7-dichloroquinoxaline-2,3-dione (DCQX).
    Yoneda Y; Ogita K
    Biochem Biophys Res Commun; 1989 Oct; 164(2):841-9. PubMed ID: 2554902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An endogenous modulator of N-methyl-D-aspartate receptor-coupled glycine receptors.
    Marvizón JC; Skolnick P
    Eur J Pharmacol; 1990 Jan; 188(1):23-32. PubMed ID: 2155119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential modulation by divalent cations of [3H]MK-801 binding in brain synaptic membranes.
    Enomoto R; Ogita K; Han D; Yoneda Y
    J Neurochem; 1992 Aug; 59(2):473-81. PubMed ID: 1378487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycine modulation of NMDA-evoked release of [3H]acetylcholine and [3H]dopamine from rat striatal slices.
    Ransom RW; Deschenes NL
    Neurosci Lett; 1989 Jan; 96(3):323-8. PubMed ID: 2541381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative autoradiography of [3H]-MK-801 binding sites in mammalian brain.
    Bowery NG; Wong EH; Hudson AL
    Br J Pharmacol; 1988 Apr; 93(4):944-54. PubMed ID: 3291999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential potentiation by spermidine of abilities of a variety of displacers for [3H]MK-801 binding in hippocampal synaptic membranes.
    Enomoto R; Ogita K; Han D; Yoneda Y
    Neurosci Res; 1993 Mar; 16(3):217-24. PubMed ID: 8098144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.
    Procter AW; Wong EH; Stratmann GC; Lowe SL; Bowen DM
    J Neurochem; 1989 Sep; 53(3):698-704. PubMed ID: 2569500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiles of [3H]N-[1-(2-thienyl)cyclohexyl]piperidine binding in brain synaptic membranes treated with Triton X-100.
    Ogita K; Suzuki T; Enomoto R; Ohgaki T; Katagawa J; Uchida S; Meguri H; Yoneda Y
    Neurosci Res; 1990 Sep; 9(1):35-47. PubMed ID: 2175865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supporting evidence for negative modulation by protons of an ion channel associated with the N-methyl-D-aspartate receptor complex in rat brain using ligand binding techniques.
    Yoneda Y; Enomoto R; Ogita K
    Brain Res; 1994 Feb; 636(2):298-307. PubMed ID: 7516810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N-methyl-D-aspartate (NMDA) receptor complex: a stoichiometric analysis of radioligand binding domains.
    Thedinga KH; Benedict MS; Fagg GE
    Neurosci Lett; 1989 Sep; 104(1-2):217-22. PubMed ID: 2573014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycine binding to rat cortex and spinal cord: binding characteristics and pharmacology reveal distinct populations of sites.
    White WF; Brown KL; Frank DM
    J Neurochem; 1989 Aug; 53(2):503-12. PubMed ID: 2545818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.
    Birch PJ; Grossman CJ; Hayes AG
    Eur J Pharmacol; 1988 Sep; 154(1):85-7. PubMed ID: 2846328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo characterization of the NMDA receptor-linked strychnine-insensitive glycine site.
    Peeters BW; Vanderheyden PM
    Epilepsy Res; 1992 Jul; 12(2):157-62. PubMed ID: 1356759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]D-serine labels strychnine-insensitive glycine recognition sites of rat central nervous system.
    Danysz W; Fadda E; Wroblewski JT; Costa E
    Life Sci; 1990; 46(3):155-64. PubMed ID: 2154648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801).
    Lyle TA; Magill CA; Britcher SF; Denny GH; Thompson WJ; Murphy JS; Knight AR; Kemp JA; Marshall GR; Middlemiss DN
    J Med Chem; 1990 Mar; 33(3):1047-52. PubMed ID: 2155319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of binding at strychnine-sensitive (inhibitory glycine receptor) and strychnine-insensitive (N-methyl-D-aspartate receptor) glycine binding sites.
    Pullan LM; Powel RJ
    Neurosci Lett; 1992 Dec; 148(1-2):199-201. PubMed ID: 1338650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kynurenate and 2-amino-5-phosphonovalerate interact with multiple binding sites of the N-methyl-D-aspartate-sensitive glutamate receptor domain.
    Danysz W; Fadda E; Wroblewski JT; Costa E
    Neurosci Lett; 1989 Jan; 96(3):340-4. PubMed ID: 2566140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HA-966 acts at a modulatory glycine site to inhibit N-methyl-D-aspartate-evoked neurotransmitter release.
    Keith RA; Mangano TJ; Meiners BA; Stumpo RJ; Klika AB; Patel J; Salama AI
    Eur J Pharmacol; 1989 Aug; 166(3):393-400. PubMed ID: 2572428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (+)-[3H]MK-801 binding sites in postmortem human brain.
    Quarum ML; Parker JD; Keana JF; Weber E
    J Neurochem; 1990 Apr; 54(4):1163-8. PubMed ID: 2156014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
    Carter CJ; Lloyd KG; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.